Meetings
Medicines Management
This page gives details of any meetings held which will, or did, discuss the matter, and includes links to the relevant Papers, Agendas and Minutes.
Note: Meeting Agenda can change at short notice. Particularly where future meeting dates are indicated more than a week in advance. Please check before planning to attend a Committee Meeting that the item you are interested in has not been moved.
Meeting: 07/12/2020 - Public Accounts Committee - Fifth Senedd (Item 3)
3 Medicines Management: Letter from the Welsh Government (16 November 2020)
Supporting documents:
Meeting: 21/09/2020 - Public Accounts Committee - Fifth Senedd (Item 2)
2 Medicines Management: Letter from the Welsh Government (28 August 2020)
Supporting documents:
Meeting: 24/02/2020 - Public Accounts Committee - Fifth Senedd (Item 2)
2 Medicines Management: Letter from the Welsh Government (10 February 2020)
Supporting documents:
Meeting: 06/01/2020 - Public Accounts Committee - Fifth Senedd (Item 2)
2 Medicines Management: Letter from the Welsh Government (10 December 2019)
Supporting documents:
Meeting: 29/04/2019 - Public Accounts Committee - Fifth Senedd (Item 2)
2 Medicines Management: Letter from Welsh Government (April 2019)
Supporting documents:
Meeting: 04/02/2019 - Public Accounts Committee - Fifth Senedd (Item 2)
2 Medicines Management: Letter from the Welsh Government (17 January 2019)
Supporting documents:
Meeting: 01/10/2018 - Public Accounts Committee - Fifth Senedd (Item 4)
4 Medicines Management: Letter from the Welsh Government (15 August 2018)
Supporting documents:
Meeting: 11/06/2018 - Public Accounts Committee - Fifth Senedd (Item 3)
3 Medicines Management: Consideration of responses to report recommendations
PAC(5)-16-18
Paper 1 – Welsh Government Response (2 May 2018)
PAC(5)-16-18
Paper 2 – Welsh Government Response (31 May 2018)
PAC(5)-16-18
Paper 3 – Letter from the Auditor General for Wales
Supporting documents:
- PAC(5)-16-18 P1 - Welsh Government response Medicines Management 2 May, item 3
PDF 332 KB View as HTML (3/1) 62 KB
- PAC(5)-16-18 P2 - Welsh Government response Medicines Management 31 May, item 3
PDF 711 KB
Minutes:
3.1
The Committee noted the responses and it was agreed that the Chair will write
to the Welsh Government seeking clarification on a number of the responses to
the Committee’s recommendations.
Meeting: 05/03/2018 - Public Accounts Committee - Fifth Senedd (Item 1)
1 Medicines Management: Consideration of the draft report
PAC(5)-07-18
Paper 1 – Draft Report
Supporting documents:
- Restricted enclosure 36 , View reasons restricted (1/1)
Minutes:
1.1
Members considered and agreed the draft report.
Meeting: 26/02/2018 - Public Accounts Committee - Fifth Senedd (Item 1)
1 Medicines Management: Consideration of draft Report
PAC(5)-06-18
Paper 1 – Draft Report
Supporting documents:
- Restricted enclosure 40 , View reasons restricted (1/1)
Minutes:
1.1
Members considered the draft report and due to time constraints agreed to
return to it at next week’s meeting.
Meeting: 20/11/2017 - Public Accounts Committee - Fifth Senedd (Item 2)
2 Medicines Management: Additional information from the Welsh Government (30 October 2017)
Supporting documents:
Meeting: 13/11/2017 - Public Accounts Committee - Fifth Senedd (Item 2.1)
Medicines Management: Additional information from the Welsh Government (30 October 2017)
Meeting: 16/10/2017 - Public Accounts Committee - Fifth Senedd (Item 5)
Medicines Management: Evidence Session - GP Cluster Group from Aneurin Bevan University Health Board
Dr Alun Edwards - Ty Bryn Surgery, Caerphilly
Dr Alun Walters -
Clinical Director, Primary Care & Community Service, Aneurin Bevan University
Health Board
Eryl Smeethe - Pharmacist and Neighbourhood Care Networks Lead Torfaen North, Aneurin Bevan University Health Board
Minutes:
5.1
The Committee took evidence from Dr Alun Edwards, Ty Bryn Surgery, Caerphilly;
Dr Alun Walters, Clinical Director, Primary Care & Community Service,
Aneurin Bevan University Health Board and Eryl Smeethe, Pharmacist and Neighbourhood
Care Networks Lead Torfaen North, Aneurin Bevan University Health Board as part
of the inquiry on medicines management.
Meeting: 16/10/2017 - Public Accounts Committee - Fifth Senedd (Item 6)
Medicines Management: Evidence Session - Welsh Government
Research
Briefing
Andrew
Evans – Chief Pharmaceutical Officer, Welsh Government
Professor
Chris Jones - Deputy Chief Medical Officer, Welsh Government
Minutes:
6.1
The Committee took evidence from Andrew Evans, Chief Pharmaceutical Officer and
Professor Chris Jones, Deputy Chief Medical Officer, Welsh Government as part
of the inquiry on medicines management.
6.2
Andrew Evans agreed to send further information on the anticipated roll out date
for the MTeD (Medicines Transcribing and e-Discharge) system across Wales.
Meeting: 16/10/2017 - Public Accounts Committee - Fifth Senedd (Item 4)
4 Medicines Management: Evidence Session - GP Cluster Group from Hywel Dda University Health Board
Research
Briefing
Dr
Carwyn Jones - Furnace House Surgery, Carmarthen
Dr
Darren Chant - Meddygfa Teifi, Llandysul
Supporting documents:
- Restricted enclosure 53 , View reasons restricted (4/1)
Minutes:
4.1
The Committee took evidence from Dr Carwyn Jones, Furnace House Surgery,
Carmarthen and Dr Darren Chant, Meddygfa Teifi, Llandysul as part of the
inquiry on medicines management.
Meeting: 16/10/2017 - Public Accounts Committee - Fifth Senedd (Item 8)
Medicines Management: Consideration of evidence received
Minutes:
8.1
Members considered the evidence received and asked the Clerks to prepare a
draft report.
Meeting: 16/10/2017 - Public Accounts Committee - Fifth Senedd (Item 3)
3 Medicines Management: Correspondence
PAC(5)-26-17
Paper 1 – Letter from Royal College of General Practitioners (4 September 2017)
Supporting documents:
Minutes:
3.1
Members considered and noted the letter from the Royal College of General
Practitioners.
Meeting: 17/07/2017 - Public Accounts Committee - Fifth Senedd (Item 3)
3 Medicines Management: Reports from Stakeholder Event
PAC(5)-21-17
Paper 1 – Report from visit to Glanrhyd Surgery, Ebbw Vale
PAC(5)-21-17
Paper 3 – Report from visit to Ty Elli Surgery, Llanelli
PAC(5)-21-17
Paper 3 – Report from visit to Stanwell Surgery, Penarth
PAC(5)-21-17
Paper 4 – Additional information from Abertawe Bro Morgannwg University Health
Board (ABMUHB)
Supporting documents:
- PAC(5)-21-17 P1 - Report from visit to Glanrhyd Surgery, Ebbw Vale, item 3
PDF 31 KB View as HTML (3/1) 8 KB
- PAC(5)-21-17 P2 - Report from visit to Ty Elli Surgery, Llanelli, item 3
PDF 80 KB View as HTML (3/2) 18 KB
- PAC(5)-21-17 P3 – Report from visit to Stanwell Surgery, Penarth, item 3
PDF 31 KB View as HTML (3/3) 7 KB
- PAC(5)-21-17 P4 - Additional information from Abertawe Bro Morgannwg University Health Board (ABMUHB) , View reasons restricted (3/4)
Minutes:
3.1
The papers were noted.
3.2
Members agreed to gather further evidence in the autumn term.
Meeting: 19/06/2017 - Public Accounts Committee - Fifth Senedd (Item 4)
4 Medicines Management: Evidence Session 3
PAC(5)-17-17
Paper 1 – Paper from Cwm Taf University Health Board
PAC(5)-17-17
Paper 2 – Paper from Powys Teaching Health Board
PAC(5)-17-17
Paper 3 – Paper from Abertawe Bro Morgannwg University Health Board
Allison
Williams – Chief Executive, Cwm Taf University Health Board
Suzanne
Scott-Thomas, Chief Pharmacist, Cwm Taf University Health Board
Professor
Rory Farrelly – Acting Chief Operating Officer/Deputy Chief Executive &
Director of Nursing and Patient Evidence, Abertawe Bro Morgannwg University
Health Board
Judith
Vincent – Clinical Director for Pharmacy and Medicines Management, Abertawe Bro
Morgannwg University Health Board
Carol
Shillabeer – Chief Executive, Powys Teaching Health Board
Karen
Gully – Medical Director, Powys Teaching Health Board
Supporting documents:
- PAC(5)-17-17 P1 - Paper from Cwm Taf UHB, item 4
PDF 1 MB View as HTML (4/1) 108 KB
- PAC(5)-17-17 P2 - Paper from Powys Teaching Health Board, item 4
PDF 460 KB
- PAC(5)-17-17 P3 - Paper from ABMUHB, item 4
PDF 7 MB
Minutes:
4.1
The Committee took evidence from Allison Williams, Chief Executive, Cwm Taf
University Health Board; Suzanne Scott-Thomas, Chief Pharmacist, Cwm Taf
University Health Board; Professor Rory Farrelly, Acting Chief Operating
Officer/Deputy Chief Executive & Director of Nursing and Patient Evidence,
Abertawe Bro Morgannwg University Health Board; Judith Vincent, Clinical
Director for Pharmacy and Medicines Management, Abertawe Bro Morgannwg
University Health Board; Carol Shillabeer, Chief Executive, Powys Teaching
Health Board and Karen Gully, Medical Director, Powys Teaching Health Board as
part of their inquiry into medicines management.
4.2
Judith Vincent agreed to provide additional information on the work Professor
Routledge is facilitating with experts on medicines related admissions regarding
patient safety.
Meeting: 19/06/2017 - Public Accounts Committee - Fifth Senedd (Item 3)
3 Medicines Management: Evidence Session 2
Research
Briefing
Judy
Henley – Director of Contractor Services, Community Pharmacy Wales
Mark
Griffiths - Chair of Community Pharmacy Wales
Mair
Davies - Director, Royal Pharmaceutical Society Wales
Cheryl
Way – RPS Board Member (Principal Pharmacist, Cardiff and Vale University Health
Board and National Pharmacy and Medicines Management Lead, NHS Wales
Informatics Service)
Supporting documents:
- Restricted enclosure 76 , View reasons restricted (3/1)
Minutes:
3.1
The Committee took evidence from Judy Henley, Director of Contractor Services,
Community Pharmacy Wales; Mark Griffiths, Chair of Community Pharmacy Wales; Elen
Jones, Practice and Policy lead for Royal Pharmaceutical
Society Wales and Cheryl Way, RPS Board Member (Principal Pharmacist, Cardiff
and Vale University Health Board and National Pharmacy and Medicines Management
Lead, NHS Wales Informatics Service) as part of their inquiry into medicines
management.
3.2 The Committee noted that Elen Jones had attended in place of Mair Davies, Director of RPS Wales due to sickness.
Meeting: 19/06/2017 - Public Accounts Committee - Fifth Senedd (Item 6)
Medicines Management: Consideration of evidence received
Minutes:
6.1
Members considered the evidence received.
Meeting: 08/05/2017 - Public Accounts Committee - Fifth Senedd (Item 2)
2 Medicines Management: Additional information from the Welsh Government (28 April 2017)
Supporting documents:
Meeting: 27/03/2017 - Public Accounts Committee - Fifth Senedd (Item 2)
2 Medicines Management: Letter from Boots (9 March 2017)
Supporting documents:
- PAC(5)-10-17 PTN2 - Letter from Boots re medicines management (9 March), item 2
PDF 206 KB View as HTML (2/1) 17 KB
Meeting: 06/03/2017 - Public Accounts Committee - Fifth Senedd (Item 3)
3 Medicines Management: Evidence Session with the Welsh Government
Research
Briefing
PAC(5)-08-17
Paper 1 – Welsh Government’s response to the Auditor General for Wales’
Report on Managing Medicines in Primary
and Secondary Care
Dr
Andrew Goodall - Director General/NHS Chief Executive
Andrew
Evans - Chief Pharmaceutical Officer, Welsh Government
Jean
White - Chief Nursing Officer, Welsh Government
Alan
Brace - Director of Finance, Welsh Government
Supporting documents:
- Restricted enclosure 90 , View reasons restricted (3/1)
- PAC(5)-08-17 P1 - WG response to AGW Report - Managing Medicines_e, item 3
PDF 174 KB
Minutes:
3.1
The Committee took evidence from Dr Andrew Goodall, Director General/NHS Chief
Executive; Andrew Evans, Chief Pharmaceutical Officer; Professor Jean White,
Chief Nursing Officer; and Alan Brace, Director of Finance, Welsh Government as
part of its inquiry into medicines management.
3.2
Dr Goodall agreed to undertake an evaluation on the numbers of wards using
automatic medicine vending of medicines and will also look to clarify tensions
in the system at the same time.
3.3
The Committee agreed to take further evidence from health boards in the
summer term.
Meeting: 06/03/2017 - Public Accounts Committee - Fifth Senedd (Item 5)
Medicines Management: Consideration of evidence received
Minutes:
5.1
Members considered the evidence received.
Meeting: 30/01/2017 - Public Accounts Committee - Fifth Senedd (Item 8)
8 Medicines Management: Auditor General for Wales' Report
Research
Briefing
PAC(5)-04-17
Paper 8 – Auditor General for Wales’s report
PAC(5)-04-17
Paper 9 – Welsh Government Response to Auditor General for Wales’s report
Supporting documents:
- Restricted enclosure 97 , View reasons restricted (8/1)
- PAC(5)-04-17 P8 - AGW Report on Medicines management, item 8
PDF 1 MB
- PAC(5)-04-17 P9 - WG response on Medicines Management, item 8
PDF 229 KB View as HTML (8/3) 38 KB
Minutes:
8.1 The Committee received a briefing on the Auditor General for Wales’ report on his recent report on medicines management.
8.2 The Committee agreed to hold an evidence session with the Welsh Government on this issue in spring 2017.